Varex Imaging Reports Significant Earnings and Revenue Beat
Varex Imaging Corporation (NASDAQ:VREX) on November 18, 2025, announced quarterly earnings per share (EPS) of $0.37, significantly surpassing the consensus estimate of $0.18. This represents an earnings surprise of more than 105%. The medical imaging component supplier also reported revenues of approximately $228.9 million, exceeding the Zacks Consensus Estimate of $205.8 million by 3.83%.
This report marks the fourth consecutive quarter in which Varex has outperformed consensus EPS estimates. In the previous quarter, the company posted an EPS of $0.18 against an estimate of $0.04, delivering a 350% surprise. This pattern of performance highlights the company's consistent financial results.
The company's financial stability is underscored by several key metrics. Varex maintains a low debt-to-equity ratio of 0.06, indicating minimal leverage. Furthermore, its current ratio of 3.43 suggests a strong liquidity position, with current assets substantially covering current liabilities. For more details, see the company's financial health overview.
Valuation metrics indicate a price-to-sales ratio of 0.58. The enterprise value to sales ratio is 0.45, suggesting the company's total valuation is below its annual sales. Investors seeking more information can view the Varex investor profile.
Varex Imaging Corporation (VREX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.